Indeed, we detected increase of catalase transcript levels in both MEC1/DHL6 cells (Fig. 4G) as well as in primary CLL cells (Fig. 4H) treated with AZA. This evidence concerns the gene CAT and B-cell chronic lymphocytic leukemia.